Every tirzepatide product the FDA has approved Zepbound for chronic weight management and obstructive sleep apnea, and Mounjaro for glycemic control in type 2 diabetes is a subcutaneous injection
The patent system protects brand medications from generic competition for years, allowing manufacturers to maintain monopoly pricing
Contact us today to learn more about the practice and all of the services we offer in Naples, Fort Myers, Bonita Beach, Miami, and Orlando, Florida
Both are unlicensed in the UK, and their combined use should only ever be considered under close specialist supervision, ideally within a formal clinical trial setting
In a head-to-head, once-daily lixisenatide was non-inferior to exenatide BID for A1c, with possibly slightly less nausea (owing to the gradual dose titration) but slightly less weight loss as well